Skip to search formSkip to main contentSkip to account menu

epidepride

Known as: Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-iodo-2,3-dimethoxy-, (S)-, N-((1-ethyl-2-pyrrolidinyl)-methyl)-5-iodo-2,3-dimethoxybenzamide 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

BenzamidesContrast MediaPyrrolidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain.
[(123)I]Epidepride, [(18)F]fallypride, and [(76)Br]isoremoxipride (FLB-457) and their corresponding [(11)C]labeled derivatives… 
2001
2001
Synthesis and ~(131)I Labeling of Epidepride as a Dopamine D_2 Receptor Imaging Agent
S (-) N [(1 ethyl 2 pyrrolidinyl)methyl] 5 iodo 2,3 dimethoxybenzamide (Epidepride) and its iodine labeling precursor S (-) N [(1… 
2001
2001
Preparation of Epidepride
  • M. Hu
  • 2001
  • Corpus ID: 98981322
OBJECTIVE:To study the synthesis method of Epidepride.METHOD:Taking 3 methoxysalicylic acid as the starting material,epidepride… 
2000
2000
Metabolism of [123I]epidepride may affect brain dopamine D2 receptor imaging with single-photon emission tomography
Abstract.Iodine-123 labelled epidepride is a novel radiopharmaceutical for the study of cerebral dopamine D2 receptors using… 
1999
1999
Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography
Abstract. Epidepride labelled with iodine-123 is a suitable probe for the in vivo imaging of striatal and extrastriatal dopamine… 
1999
1999
Clinical deficits in Huntington disease correlate with reduced striatal uptake on iodine-123 epidepride single-photon emission tomography
Abstract. Huntington disease (HD) is characterized by severe abnormalities in neurotransmitter concentrations and neuroreceptor… 
1997
1997
A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.
The usefulness of 123I-epidepride as a single photon emission computed tomography (SPECT) scan D2 receptor ligand was examined in… 
1995
1995
Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand.
UNLABELLED Substituted benzamides have been shown to have very high affinity and specificity for the dopamine D2 receptor. One of… 
1994
1994
Formation of 1-[123I]iodobutane in labeling [123I]iomazenil by iododestannylation: implications for the reaction mechanism.
1994
1994
Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2'-ISP in nonhuman primates.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)